Rhumbline Advisers Athenex, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.41 - $0.91 $43,885 - $97,404	-107,038 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.79 - $1.59 $1,657 - $3,335	-2,098 Reduced 1.92%	107,038 $89,000
Q4 2021 Feb 10, 2022	SELL	$1.36 - $2.94 $2,598 - $5,618	-1,911 Reduced 1.72%	109,136 $148,000
Q3 2021 Nov 12, 2021	SELL	$2.97 - $4.84 $12,471 - $20,323	-4,199 Reduced 3.64%	111,047 $334,000
Q2 2021 Aug 05, 2021	BUY	$3.71 - $5.13 $59,853 - $82,762	16,133 Added 16.28%	115,246 $532,000
Q1 2021 May 06, 2021	SELL	$4.08 - $14.75 $807 - $2,920	-198 Reduced 0.2%	99,113 $426,000
Q4 2020 Feb 10, 2021	BUY	$11.06 - $14.01 $65,331 - $82,757	5,907 Added 6.32%	99,311 $1.1 Million
Q3 2020 Nov 12, 2020	SELL	$10.26 - $14.55 $229,546 - $325,527	-22,373 Reduced 19.32%	93,404 $1.13 Million
Q2 2020 Aug 13, 2020	BUY	$7.11 - $13.76 $161,141 - $311,856	22,664 Added 24.34%	115,777 $1.59 Million
Q1 2020 May 06, 2020	BUY	$5.71 - $15.85 $32,238 - $89,489	5,646 Added 6.46%	93,113 $721,000
Q4 2019 Feb 05, 2020	BUY	$9.6 - $17.75 $17,913 - $33,121	1,866 Added 2.18%	87,467 $1.34 Million
Q3 2019 Oct 23, 2019	BUY	$12.16 - $21.0 $112,504 - $194,292	9,252 Added 12.12%	85,601 $1.04 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $191,849 - $402,395	20,323 Added 36.27%	76,349 $1.51 Million
Q1 2019 May 01, 2019	SELL	$11.11 - $13.49 $5,321 - $6,461	-479 Reduced 0.85%	56,026 $686,000
Q4 2018 Jan 31, 2019	BUY	$10.24 - $15.49 $197,345 - $298,523	19,272 Added 51.76%	56,505 $717,000
Q3 2018 Nov 07, 2018	SELL	$15.53 - $19.97 $29,631 - $38,102	-1,908 Reduced 4.87%	37,233 $579,000
Q2 2018 Aug 06, 2018	BUY	$15.88 - $19.5 $621,559 - $763,249	39,141 New	39,141 $730,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account